To Patients With Cancer and Health Care Providers About COVID-19

The FDA Oncology Center of Excellence recognizes that patients with cancer constitute a vulnerable population at risk of contracting the coronavirus disease (COVID-19). While everyone’s daily lives have been disrupted during the COVID-19 pandemic, the impact may be hardest on those with acute or chronic medical conditions and those with weakened immune systems, such as that caused by cancer and some forms of cancer treatment.  

We also recognize that oncology care providers themselves are faced with immense daily personal and professional challenges. Many of our colleagues are on the front lines of caring for patients with cancer, concerned about protecting the safety of their patients, as well as themselves and their families, while assuring their patients’ access to needed treatment and clinical trials.

In this critical time, we want you to know that we are here for patients with cancer and their health care providers and we will do everything we can to help you through this difficult period. Although our nation’s emphasis is on the need to combat this virus, patients with cancer and their unique needs continue to be a top priority.

For more information, please visit the following webpage:

We also encourage you to follow @FDAOncology on Twitter and check our website for regular updates.


LRG Staff
Author: LRG Staff